Vimarsana
Biggest News Aggregation in the World

Page 6 - Pharmaceutical Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Technology Today - Breaking & Trending Today

ESCMID 2024: Using AI in infection prevention and control - Vimarsana News

ESCMID 2024: Using AI in infection prevention and control

Artificial intelligence tools can be used for infection control through facial recognition systems designed to identify proper face mask use within hospitals.

Source: yahoo.com
Pioneer Institute study finds IRA discourages non-opioid drug innovation - Vimarsana News

Pioneer Institute study finds IRA discourages non-opioid drug innovation

The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.

Source: yahoo.com
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks - Vimarsana News

Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks

Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.

Source: yahoo.com
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments - Vimarsana News

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring Oncolytics Biotech® Inc. , a clinical-stage...

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX) - Vimarsana News

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)